Adage Capital Partners’s Zymeworks ZYME Stock Holding History
Bought
Maintained
Sold
Other funds holding ZYME
EC
RCMNY
BI
PA
VCM
Adage Capital Partners's ZYME Position: Q1 2026 in Review
Adage Capital Partners sold out of Zymeworks (ZYME) in Q1 2026, closing a stake of 663,546 shares — an estimated $17.5M sold.
Adage Capital Partners first reported a position in ZYME in Q2 2025 and held it in 3 quarters. The position peaked at $17.5M in Q4 2025. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.
- Adage Capital Partners reported no remaining Zymeworks position as of Q1 2026 after selling out during the quarter.
- Adage Capital Partners sold 663,546 Zymeworks shares in Q1 2026, an estimated $17.5M.
- Adage Capital Partners first reported a position in Zymeworks in Q2 2025 and held it in 3 quarters.
- Adage Capital Partners's Zymeworks position peaked at $17.5M in Q4 2025.
- 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.
Based on Adage Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.